Biotech Stocks List USA 2023: FKnol.com

Most Read Articles: Warren Buffett's Stock Picking Indicators, and Investment Strategies for a Bear Market.
Biotechnology has emerged as one of the key areas of interest amid the Health Care sector. Hundreds of biotech companies have mushroomed whose size varies from 5 person teams to thousands of employees who are involved in path-breaking research, associated development, and attempts to find cure to a variety of diseases and ailments. Companies in the biotechnology subsector usually have a very high operating cost owing to their research-, development-, and testing-focused activities which may not only take years to complete, but the end result is also highly uncertain. Success may lead to the biotech company coming out with a high-price patented drug that can make millions or billions making the stock a multi-bagger, while a failure can lead to a complete wipeout of equity value. Investors in such biotech stocks should be prepared for a volatile change in stock prices.

As of writing, FKnol has the following Biotech stocks in its database. This article presents the performance of the Biotech stocks in a tabular form making it easy for individuals to sort the list on the desired parameters of preference. Details are based on the market data for the year 2023 till date. This article presents a list of all Biotech stocks, which can be sorted and assessed for the past performance of the Biotech stocks based on market capitalization values, stock price, price changes, percentage price changes and 52-week high-low price ranges. Percentage change is calculated based on the price changes observed from the end of the previous year to the date of Sep 15, 2023.

Sector-wise U.S. Stock Screener

There are a total of 706 company stocks in FKnol records which have business operations in the Biotech segment / category. Explore the full list as follows.
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.

Top Performing Biotech StocksAll Biotech StocksAll Biotech Mutual FundsAll Biotech ETFsTop Dividend-paying Biotech StocksTop Biotech Stocks for Oct 2023

Performance of Biotech Stocks

🡄 1-24 25-48 49-72 73-96 97-120 121-144 145-168 169-192 193-216 217-240 241-264 265-288 289-312 313-336 337-360 361-384 385-408 409-432 433-456 457-480 481-504 505-528 529-552 553-576 577-600 601-624 625-648 649-672 673-696 697-706 🡆

Company (Ticker)	Market Cap	%YTD Gains	Company Description	Stock Price	52-wk Price Range	PE fwd	PE trail	EPS ttm
Sorted by Company Name. Click on the arrow buttons to sort the table as per the desired column
1) 180 Life Sciences Corp. (ATNF)	$4.95 million	-75.6%	180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, ...See Detailed Company Profile	$0.8272	$0.51 - $18.00	-1.8	0	-38.66
2) 22nd Century (XXII)	$27.82 million	43.4%	22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoid ...See Detailed Company Profile Dividend History List of ETFs holding XXII	$1.32	$1.16 - $21.75	-1.5	0	-5.19
3) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Biotechnology sub-sector of the US market has the following business profile. ...See Detailed Company Profile	Members Only! Login / Register to view or

4) 89Bio (ETNB)	$1.31 billion	36.37%	89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate, BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 that is being developed for the treatment of nonalcoholic steatohepatitis. The company also intends to develop BIO89-100 for the treat ...See Detailed Company Profile Dividend History List of ETFs holding ETNB	$17.36	$4.85 - $22.93	-6.89	0	-1.55
5) Aadi Bioscience, Inc. (AADI)	$135.84 million	-56.82%	Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing precision therapies for genetically-defined cancers with ...See Detailed Company Profile	$5.54	$5.06 - $14.77	-1.9	0	-2.23
6) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Biotechnology sub-sector of the US market has the following business profile. ...See Detailed Company Profile	Members Only! Login / Register to view or

7) AbCellera Biologics Inc. (ABCL)	$1.55 billion	-47.29%	AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of ...See Detailed Company Profile	$5.34	$5.12 - $14.97	-8.75	0	-0.27
8) Abeona Therapeutics (ABEO)	$99.77 million	30.84%	Abeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., incorporated on June 22, 1989, is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Companys lead ...See Detailed Company Profile Dividend History List of ETFs holding ABEO	$4.03	$2.19 - $5.80	-2.06	0	-1.82
9) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Biotechnology sub-sector of the US market has the following business profile. ...See Detailed Company Profile	Members Only! Login / Register to view or

10) ABVC Biopharma, Inc. (ABVC)	$4.15 million	68%	American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in ...See Detailed Company Profile	$1.05	$1.03 - $18.70	-2.39	0	-3.72
11) AC Immune SA (ACIU)	$252.27 million	48.04%	AC Immune Ltd is a Switzerland-based company engaged in the medical biotechnology sector. It develops treatments for Alzheimers and other neurodegenerative diseases, such as Down syndrome, glaucoma and Parkinsons, and ...See Detailed Company Profile Dividend History List of ETFs holding ACIU	$3.02	$1.68 - $3.83	-4.95	0	-0.84
12) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Major Pharmaceuticals sub-sector of the US market has the following business profile. ...See Detailed Company Profile Dividend History List of ETFs holding Stock	Members Only! Login / Register to view or

13) Acasti Pharma (ACST)	$14.97 million	301.2%	Acasti Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing, clinically studying and marketing new pharmaceutical products to treat human cardiovascular conditions. The Company is involved ...See Detailed Company Profile Dividend History List of ETFs holding ACST	$2.01	$1.92 - $5.04	-4.9	0	-5.63
14) Acelyrin (SLRN)	$1.11 billion	0%	Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative ...See Detailed Company Profile Dividend History	$11.38	$9.76 - $29.88	-3.69	1.48	7.68
15) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Healthcare sub-sector of the US market has the following business profile. ...See Detailed Company Profile Dividend History List of ETFs holding Stock	Members Only! Login / Register to view or

16) Achieve Life Sciences (ACHV)	$97.93 million	89.39%	Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes smoking cessation aids in the United States and internationally. The company offers Cytisine, a plant-based alka ...See Detailed Company Profile Dividend History List of ETFs holding ACHV	$4.64	$2.00 - $10.30	-2.85	0	-3.03
17) Achilles Therapeutics plc (ACHL)	$36.34 million	-1.39%	Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various types of solid ...See Detailed Company Profile	$0.8875	$0.75 - $3.00	-0.64	0	-1.85
18) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Major Pharmaceuticals sub-sector of the US market has the following business profile. ...See Detailed Company Profile Dividend History List of ETFs holding Stock	Members Only! Login / Register to view or

19) Acorda Therapeutics (ACOR)	$19.07 million	1902.09%	Acorda Therapeutics, Inc., incorporated on March 17, 1995, is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. ...See Detailed Company Profile Dividend History List of ETFs holding ACOR	$15.35	$5.20 - $24.80	-15.99	1.7	9.04
20) ACRIVON THERAPEUTICS INC (ACRV)	$232.87 million	-8.42%	Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops precision oncology medicines. The companys lead clinical candidate is ...See Detailed Company Profile	$10.55	$8.06 - $25.47	-3.12	0	-1.95
21) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Major Pharmaceuticals sub-sector of the US market has the following business profile. ...See Detailed Company Profile Dividend History List of ETFs holding Stock	Members Only! Login / Register to view or

22) Acumen Pharmaceuticals, Inc. (ABOS)	$320.01 million	2.41%	Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimers and ...See Detailed Company Profile	$5.53	$3.52 - $11.31	-4.22	0	-1.14
23) Acurx Pharmaceuticals, Inc. (ACXP)	$23.02 million	-55.53%	Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate ...See Detailed Company Profile	$1.77	$1.53 - $4.61	-2.01	0	-1.2
24) Stock Biotech ZVZZT Biotech Corp Ltd. (ZVZZT)	Members Only! Login / Register to view		The Biotech stock belonging to the Biotech category, Healthcare sector and Biotechnology sub-sector of the US market has the following business profile. ...See Detailed Company Profile	Members Only! Login / Register to view or